IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Intraoperative neuromonitoring in Missouri

In 2025 Q1–Q4, the provider or facility offer prevailed in 88.1% of 5,364 determined Federal IDR dispute line items for intraoperative neuromonitoring in Missouri. The median prevailing offer was 22.00x the QPA (25th–75th percentile 8.74x–50.50x; n = 3,354). The median time to a decision was 37 business days (n = 5,364).

Determined line items

5,364

2025 Q1–Q4 · 6 split decisions excluded

Provider win rate

88.1%

n = 5,364 · 2025 Q1–Q4

Median payment vs QPA

22.00x †

middle half 8.74x–50.50x · n = 3,354 · 2025 Q1–Q4

Median days to decision

37

business days, from dispute initiation · n = 5,364 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q45,36488.1%22.00x †8.74x–50.50x3,35437
2024 Q1–Q41,81388.9%19.25x8.45x–33.79x1,38965
2023 Q1–Q411081.8%11.96x3.85x–22.28x10781.5
2023 Q1–2025 Q47,28788.2%20.96x †8.45x–44.27x4,850not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
95938 Placement of skin electrodes and measurement of stimulated sites on arms and leg1,08387.7%40.26x †73938
95941 Continuous remote monitoring of nervous system during operation, each hour82390.6%13.06x54144
95939 Placement of skin electrodes and measurement of central motor stimulation in arm58687.2%18.32x39739
95870 Needle measurement of electrical activity in arm, leg, trunk or head muscles, li47886.8%75.39x †23336
95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities44489.9%17.74x26337
95937 Testing of nerve-muscle junction30989.3%31.49x †16734
95955 Measurement of brain wave activity (EEG) outside the brain during surgery30187.0%50.28x †15634
95868 Needle measurement of electrical activity in muscles on both sides of body18988.4%20.84x †12235
95865 Needle measurement of electrical activity in voice box muscles15890.5%12.72x10935
95940 Continuous monitoring of nervous system during operation, each 15 minutes15288.2%32.41x †7334
95927 Placement of skin electrodes and measurement of stimulated sites in trunk or hea8689.5%19.46x5736
99360 Extended physician standby service, each 30 minutes3278.1%–1340
95999 Other diagnostic neurological or neuromuscular procedure3196.8%–2130

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Missouri · Intraoperative neuromonitoring in all states

FAQ

What is the Federal IDR provider win rate for intraoperative neuromonitoring in Missouri?

In 2025 Q1–Q4, the provider or facility offer was selected in 88.1% of 5,364 determined dispute line items for intraoperative neuromonitoring in Missouri. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for intraoperative neuromonitoring in Missouri?

In 2025 Q1–Q4, the median prevailing offer was 22.00x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 8.74x to 50.50x (n = 3,354 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for intraoperative neuromonitoring in Missouri?

In 2025 Q1–Q4, the median was 37 business days (n = 5,364 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR